Lobbying Filing Details

Total Spending

$50,000

Activities

3

Lobbyists

3

Gov't Entities

6

Filing Information
Filing UUID:
b5cfede5-5b94-4ee0-b665-6c8eae4aefe1
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 17, 2026 at 6:54 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jay B. Stewart
Registrant
HANCE SCARBOROUGH

Law Firm

Washington, District of Columbia
Client
ALLIANCE FOR PHARMACY COMPOUNDING

Non-profit association promoting the practice of pharmacy compounding

Texas, United States of America
Lobbying Activities (3)
Activity 1
Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Lobbyists (3)
  • MICHAEL TOMBERLIN
  • THERESA REED
  • MR. ROBERT DAVID PORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Lobbyists (3)
  • MICHAEL TOMBERLIN
  • THERESA REED
  • MR. ROBERT DAVID PORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Lobbyists (3)
  • MICHAEL TOMBERLIN
  • THERESA REED
  • MR. ROBERT DAVID PORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.